Page 3 - Prnewswire Biolinerx Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Prnewswire biolinerx ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Prnewswire Biolinerx Ltd Today - Breaking & Trending Today

BioLineRx to Report First Quarter 2023 Results on May 24, 2023

/PRNewswire/ BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a pre-commercial-stage biopharmaceutical company focused on oncology, announced today that it will. ....

United States , John Lacey , Moran Meir , Philip Serlin , Lifesci Advisors , Biolinerx Ltd , Prnewswire Biolinerx Ltd , Hold Conference Call , Chief Executive , Sci Advisors , Biolinerx Ltd , Health Care Amp Hospitals , Medical Pharmaceuticals , Pharmaceuticals , Conference Call Announcements ,

BioLineRx Regains Compliance with Nasdaq Minimum Bid Price Requirement

BioLineRx Regains Compliance with Nasdaq Minimum Bid Price Requirement
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Tel Aviv , John Lacey , Moran Meir , Tel Aviv Stock Exchange , Biolinerx Ltd , Nasdaq Stock Market , Exchange Commission , Company Adss , Prnewswire Biolinerx Ltd , Lifesci Advisors , Nasdaq Listing Rule , American Depository Shares , Private Securities Litigation Reform Act , Sci Advisors ,

BioLineRx to Report 2022 Annual Financial Results on March 22, 2023

/PRNewswire/ BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a pre-commercial-stage biopharmaceutical company focused on oncology, announced today that it will. ....

United States , Moran Meir , John Lacey , Philip Serlin , Prnewswire Biolinerx Ltd , Lifesci Advisors , Biolinerx Ltd , Hold Conference Call , Chief Executive , Sci Advisors ,

BioLineRx Appoints Tami Rachmilewitz, M.D., as Chief Medical Officer

/PRNewswire/ BioLineRx Ltd. (NASDAQ:BLRX) (TASE: BLRX), a pre-commercial-stage biopharmaceutical company focused on oncology, today announced that it has. ....

Israel General , United States , Moran Meir , John Lacey , Tami Rachmilewitz , Philip Serlin , Neuroderm Ltd , Hadassah Medical School , Lifesci Advisors , Exchange Commission On , Biolinerx Ltd , Teva Pharmaceutical Industries Ltd , Prnewswire Biolinerx Ltd , Bachelor Of Medical Sciences , Hebrew University Of Jerusalem , Years Of Clinical Development Industry Knowledge , Clinical Development , Experienced Drug Developer Brings Over , Clinical Development Industry Knowledge , Multiple Therapeutic Areas , Chief Medical , Chief Executive Officer , Chief Medical Officer , Senior Vice President , Medical Sciences , Hebrew University ,

BioLineRx Announces Results from Phase 1/2a Study of Investigational Anti-Tumor Vaccine AGI-134 in Metastatic Solid Tumors

/PRNewswire/ BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a pre-commercial-stage biopharmaceutical company focused on oncology, today announced results from. ....

United States , United Kingdom , Moran Meir , John Lacey , Philip Serlin , Prnewswire Biolinerx Ltd , Lifesci Advisors , Exchange Commission On , Biolinerx Ltd , Agalimmune Ltd , Study Met Primary Endpoint , Seek Publication , Complete Data Analysis , Chief Executive Officer , Tumor Cancer Type , Squamous Cell , Cervical Node , Private Securities Litigation Reform Act , Exchange Commission , Sci Advisors , Biolinerx Ltd ,